Tomer Guy, Buermeyer Andrew B, Nguyen Megan M, Liskay R Michael
Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon 97201, USA.
J Biol Chem. 2002 Jun 14;277(24):21801-9. doi: 10.1074/jbc.M111342200. Epub 2002 Mar 15.
MutLalpha, a heterodimer composed of Mlh1 and Pms2, is the major MutL activity in mammalian DNA mismatch repair. Highly conserved motifs in the N termini of both subunits predict that the protein is an ATPase. To study the significance of these motifs to mismatch repair, we have expressed in insect cells wild type human MutLalpha and forms altered in conserved glutamic acid residues, predicted to catalyze ATP hydrolysis of Mlh1, Pms2, or both. Using an in vitro assay, we showed that MutLalpha proteins altered in either glutamic acid residue were each partially defective in mismatch repair, whereas the double mutant showed no detectable mismatch repair. Neither strand specificity nor directionality of repair was affected in the single mutant proteins. Limited proteolysis studies of MutLalpha demonstrated that both Mlh1 and Pms2 N-terminal domains undergo ATP-induced conformational changes, but the extent of the conformational change for Mlh1 was more apparent than for Pms2. Furthermore, Mlh1 was protected at lower ATP concentrations than Pms2, suggesting Mlh1 binds ATP with higher affinity. These findings imply that ATP hydrolysis is required for MutLalpha activity in mismatch repair and that this activity is associated with differential conformational changes in Mlh1 and Pms2.
MutLα是一种由Mlh1和Pms2组成的异二聚体,是哺乳动物DNA错配修复中的主要MutL活性。两个亚基N端高度保守的基序表明该蛋白是一种ATP酶。为了研究这些基序对错配修复的重要性,我们在昆虫细胞中表达了野生型人MutLα以及在保守谷氨酸残基处发生改变的形式,预计这些改变会催化Mlh1、Pms2或两者的ATP水解。通过体外试验,我们发现任一谷氨酸残基发生改变的MutLα蛋白在错配修复中均存在部分缺陷,而双突变体则未检测到错配修复。单突变体蛋白的修复链特异性和方向性均未受影响。对MutLα的有限蛋白酶解研究表明,Mlh1和Pms2的N端结构域均会发生ATP诱导的构象变化,但Mlh1构象变化的程度比Pms2更明显。此外,Mlh1在比Pms2更低的ATP浓度下受到保护,这表明Mlh1与ATP的结合亲和力更高。这些发现表明,ATP水解是MutLα在错配修复中发挥活性所必需的,并且这种活性与Mlh1和Pms2中不同的构象变化相关。